Lumen, a health tech company that analyses people’s metabolism based on the CO2 and oxygen in their breath, has raised US$62m in Series B funding. The round was led by Pitango Venture Capital, with participating investors including, Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital and Disruptive VC.